| Issue Type | Login |
|---|---|
| Country | Japan |
| Industry | Login |
| Region | Login |
| Maturity Date | 2026-11-21 |
| Par Value | 100000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 1500.00 |
| Coupon | 2.25 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 1500.000 |
| Min. Piece | Login |
| Min. Increment | Login |
This Takeda Pharmaceutical Co corporate note has a 2.25% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 1500.00 million EUR and matures on November 21, 2026 with a last coupon date of FEB 28, 2020. |
Takeda Pharmaceutical Co., founded in 1781 and headquartered in Osaka, Japan, is a global leader in the biopharmaceutical industry focused on delivering innovative medicines to patients worldwide. The company specializes in therapeutic areas such as oncology, neuroscience, gastrointestinal conditions, and rare diseases, with a strong portfolio of key products including blood cancer treatments and immunology therapies.